Eli Lilly Australia Pty Limited—Humalog NPL insulin lispro protamine suspension 100U/mL prefilled pen

What are the defects?

Packaging mislabelled on product used for clinical study.

What are the hazards?

Illness or mistreatment.

What should consumers do?

All affected patients were identified and contacted by letter.

Eli Lilly Australia Pty Limited
Where the product was sold
New South Wales

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category